CI-SCREEN technology

	Next higher product group	cell line development (research assays)
	Status	2010-03-25 development end–posit
	Organisation	Inscreenex GmbH
	Original research	Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
	Person	Schucht, Roland (Inscreenex 201003– Managing Director before Helmholtz HZI)

Record changed: 2023-07-10

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for cell line development (research assays)

[1] Trenzyme GmbH. (10/28/20). "Press Release: Successful Anniversary Year for Trenzyme – also with Corona. Constance-based Biotechnology Company Trenzyme Celebrates Its 20th Anniversary". Konstanz....
[2] Cellink AB. (8/27/20). "Press Release: Cytena and AstraZeneca Collaborate to Develop Plate Based Microbioreactors for Cell Line Development Workflows"....
[3] Merck KGaA. (12/19/19). "Press Release: Merck Licenses Foundational CRISPR Integration Technology to Promega". Darmstadt....
[4] Merck KGaA. (11/12/19). "Press Release: Merck Licenses CRISPR Gene-Editing Technology to Evotec". Darmstadt....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)